The purpose of this study is to determine whether the clinical pathway for acute ischemic stroke(with combination of traditional Chinese medicine and western medicine) is able to improve the outcome of acute ischemic stroke and evaluate its effect on hospital day and cost, etc. Meanwhile, the study will discuss the safety and efficiency of this kind of Clinical Pathway

Eligibility Ages Eligible for Study: 18 Years to 85 Years Genders Eligible for Study: Both Accepts Healthy Volunteers: No

Criteria

Inclusion Criteria:

Those clinically diagnosed with acute ischemic stroke ； 18-85 years old； Over 6 hours and within 14 days from onset 4<=NIHSS <=22; Informed consent signed by patient or his/her family ；

Exclusion Criteria:

Hemorrhagic stroke; Cerebral hernia; Serious heart, liver, lung, kidney functional failure，malignancy; Not cooperative with physician; Psychological disorder; Already taken part in other clinical drug trial within the past 3 months

Inclusion Criteria:

• Ischemic stroke diagnosed with both criteria of traditional Chinese medicine and western medicine；
• 18-85 years old；
• Over 6 hours and within 14 days from onset
• 4<=NIHSS <=22;
• Informed consent signed by patient or his/her family ；

Exclusion Criteria:

• Hemorrhagic stroke;
• Cerebral hernia;
• Serious heart, liver, lung, kidney functional failure,malignancy;
• Not cooperative with physician;
• Psychological disorder;
• Already taken part in other clinical drug trial within the past 3 months